期刊文献+

抗凋亡基因bcl-X_L转染视网膜感光细胞的研究

Transfection of bcl-X_L into retinal photoreceptors in vitro
原文传递
导出
摘要 目的 :探讨介导抗凋亡基因bcl-XL 转染视网膜感光细胞的有效方法。方法 :采用视网膜神经胶质细胞条件培养液体外培养的视网膜感光细胞 ;用脂质体LIPOFECTAMINETM2 0 0 0介导 pEGFP -C3 -bcl-XL 转染至感光细胞 ;采用滴度为 6 5× 10 12 pfu/L的重组腺病毒rAd -gfp -bcl-XL 转染感光细胞 ;在荧光显微镜下观察感光细胞中的绿色荧光蛋白表达情况来比较脂质体、重组腺病毒转染法的转染率 ;用免疫组化比较这两种方法转染的细胞中Bcl-XL蛋白水平。结果 :脂质体、重组腺病毒转染法的转染率分别为 0 1%、 60 % ,免疫组化示重组腺病毒转染的细胞的Bcl -XL 蛋白水平较脂质体转染的细胞高。结论 :在视网膜感光细胞的基因转染中 ,腺病毒介导的目的基因bcl-XL 的转染率及表达明显高过脂质体法 ,重组腺病毒介导的基因转染法是视网膜变性性疾病基因治疗的一种较理想方法。 Objective:To investigate an optimal gene transfer method for retinal photoreceptors. Methods:pEGFP-C3-bcl-X L was transfected into retinal photoreceptors by using LIPOFECTAMINE TM2000 (LF2000),and 6.5×10 12pfu/mL rAd-gfp-bcl-X L was used to transfect retinal photoreceptors.48h after transfection,the positive photoreceptors with green fluorescence were numbered under fluorescence microscopy and the transfection efficiency was calculated.The expression level of Bcl-X L protein in the transfected photoreceptors was assessed by immunohistochemistry assay. Results:The transfection efficiency of LF2000 mediated and rAd-mediated method was 0.1% and 60%,respectively.A significant different expression of Bcl-X L protein was observed between lipofectin-transfecting and rAd-transfecting neurons. Conclusions:The transfection efficiency of rAd is higher than that of LF2000 in cultured retinal photoreceptors,and rAd is an optimal gene transfer method for gene therapy in retinal degenerative diseases.
出处 《中国实用眼科杂志》 CSCD 北大核心 2003年第11期857-860,共4页 Chinese Journal of Practical Ophthalmology
基金 国家自然科学基金 (30 2 0 0 30 7) "2 1 1工程"重点学科项目基金 (980 0 6) 广东省自然科学基金重点项目 (0 2 1 82 7)资助
关键词 抗凋亡基因 BCL-XL 基因转染 视网膜感光细胞 重组腺病毒 视网膜变性性疾病 基因治疗 Retina,Photoreceptors,Gene therapy,Lipofectin,Recombinant adeovirus
  • 相关文献

参考文献9

  • 1罗燕,唐仕波,林少芬,杨斌,郑湖玲.视网膜感光细胞纯化方法的研究[J].眼科研究,2000,18(3):198-200. 被引量:6
  • 2Barkats M, Bilang- Bleuel A, Buc - Caron MH, et al. Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases. Prog Neurobiol 1998 55 (4): 333--341.
  • 3Bennett J. Gene therapy for retinitis pigmentosa. Curr Opin Mol Ther 2000 2 (4): 420--425.
  • 4Shastry BS. Hereditary degenerative retinopathies: optimism for somatic gene therapy. IUBMB Life 2000 49 (6) : 479--484.
  • 5Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression. Science 1994 263 (5148): 802--805.
  • 6Kotin RM. Prospects for the use of adeno- associated virus as a vector for human gene therapy. Hum Gene Ther 1994 5 (7): 793--801.
  • 7Xiao X, Li J, McCown TJ, et al. Gene transfer by adeno- associated virus vectors into the central nervous system. Exp Neurol 1997 144 (1): 113--124.
  • 8Mitrophanous K, Yoon S, Rohll J, et al. Stable gene transfer to the nervous system using a non - primate lentiviral vector. Gene Ther 1999 6 (11): 1808--1818.
  • 9Dejneka NS, Auricchio A, Maguire AM, et al. Pharmacologically regulated gene expression in the retina following transduction with viral vectors. Gene Ther 2001 8 (6): 442--446.

二级参考文献2

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部